The early start of hemoperfusion decreases the mortality rate among severe COVID-19 patients: A preliminary study.
Mikaeili H, Taghizadieh A, Nazemiyeh M, Rezaeifar P, Zununi Vahed S, Safiri S, Ardalan M, Ansarin K.
Mikaeili H, et al.
Hemodial Int. 2022 Apr;26(2):176-182. doi: 10.1111/hdi.12982. Epub 2021 Dec 14.
Hemodial Int. 2022.
PMID: 34907633
Clinical Trial.
METHODS: In this clinical trial study, from April until June 2020, 68 COVID-19 patients (35 vs. 33 controls) with severe critical symptoms, and PaO(2) /FiO(2) (P/F) ratio less than 200 mmHg either received a single standard therapy or a combination of standard treatment fo …
METHODS: In this clinical trial study, from April until June 2020, 68 COVID-19 patients (35 vs. 33 controls) with severe critical symptoms, …